Non small lung cancer
Original Article Long noncoding RNA ZEB1-AS1 predicts an unfavorable prognosis of non-small lung cancer and regulates epithelial to mesenchymal transition through reducing ZEB1 expression
... broad spectrum of physiological and pathologi- cal processes [6]. Pathologically, lncRNAs have been reported to be implicated in tumor initia- tion and progression, and the associations between lncRNAs and cancer ...
8
Studying combined effects of chemotherapy and radiotherapy on blood cell counts in lung cancer patients
... Lung cancer is the main cause of cancer death both in males and ...of lung cancer; small cell lung carcinoma (SCLC) and non-small cell lung carcinoma ...
8
Expression of Derlin-1 and its effect on expression of autophagy marker genes under endoplasmic reticulum stress in lung cancer cells
... various lung cancer cells, including small lung cancer cells and non-small lung cancer ...most non-small lung cancer cells than ...
5
An immunohistochemical study of cyclin dependent kinase 5 (CDK5) expression in non small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker
... in cancer is ...in cancer tissue ...prostate cancer, breast cancer, medullary thyroid carcinoma, pituitary adenoma, and hepatocellular carcinoma, and CDK5 gene amplification was found in ...
8
In vivo selection for spine-derived highly metastatic lung cancer cells is associated with increased migration, inflammation and decreased adhesion
... in lung cancer, in which the vertebral column is the most frequently affected region ...of lung cancer metastasis to the spine have been poorly ...by non-invasive, real-time ...
13
Original Article Downregulation of TMEM176A suppresses cell growth and proliferationin non-small cell lung cancer
... Abstract: As a member of membrane-spanning 4A family, transmembrane protein 176A (TMEM176A) has been recently reported to be overexpressed in various cancers. However, the biological functions of TMEM176A in non- ...
9
1 2B adenosine receptor and cancer 2
... with non-small cell lung cancer, breast cancer, ovarian cancer, colorectal and six other types of cancers.. 473.[r] ...
23
An adherent subline of a unique small cell lung cancer cell line downregulates antigens of the neural cell adhesion molecule
... Small-cell lung cancer (SCLC) lines are distinguished from non-small-cell lung cancer (NSCLC) lines by their growth in floating aggregates, in contrast to the adherent ...
8
Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation
... Discussion: Histologic transformation from NSCLC to SCLC can be explained by the pres- ence of a common cell precursor. Proposed molecular mechanisms include loss of RB1, TP53 mutations, and MYC amplification. The ...
6
Vaccines in Non Small Cell Lung Cancer
... in cancer has experienced an important development with the inclusion of ...In lung cancer this type of treatment has emerged and vaccines can be classified in three groups: antigen-spe- cific ...
6
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
... various lung cancer cell lines as A427, A549 and H322, HTB171 and also in HeLa cervix cancer ...H358 lung cancer cells however expressed ZAR1 ...the lung (set 100%), but ...
12
FDG PET in the evaluation of response to nivolumab in recurrent non small cell lung cancer
... Case presentation: We report on a 75-year-old man on nivolumab treatment for metastatic non-small cell lung cancer. He had undergone right lower lobectomy for lung adenocarcinoma in the ...
5
FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC
... in cancer progression [10 – ...breast cancer cells, leading to tamoxifen resistance ...breast cancer [15], and FOXQ1 inhibition with diallyl disulfide is a novel strategy for suppressing breast CSCs ...
12
Novel classes of non coding RNAs and cancer
... colorectal cancer [83], gli- omas [84] and esophageal squamous cell carcinomas ...gastric cancer tissues was similar to that of Ki67 and suppression of HIWI induced cell cycle arrest in G2/M phase ...of ...
21
Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase
... NSCLC: non-small cell lung cancer; SCLC: small cell lung cancer; EMT: epithelial-mesenchymal transition; 16HBE: normal human bronchial epithelial cells; LC-MS/MS: liquid ...
16
Original Article The identification of genes associated with NSCLC prognosis based on an integrated bioinformatics analysis
... pancreatic cancer and correlated with patients’ poor prognosis ...resected non-small-cell lung cancer stage I-IIIA, a pre- liminary report by immunohistochemical assay ...in ...
8
Original Article Period 3, a tumor suppressor in non-small cell lung cancer, is silenced by hypermethylation
... reased in the NSCLC cell lines (A549 and H1650) compared with HEB cells (Figure 1B). We further investigated the under- lying mechanisms of PER3 silence. We performed MSP to examine the promoter meth- ylation status of ...
9
Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo
... (NSCLC): non-small cell lung cancer; (SCLC): small cell lung cancer; (TQ): Thymoquinone; (EAC): Ehrlic ascites sarcoma; (CDDP): Cisplatin; (PLKs): Polo like kinases; ...
11
The roles of metallothioneins in carcinogenesis
... ovarian cancer [22, 118], breast cancer [119, 120], small cell lung cancer [121], non-small cell lung cancer [122], renal cell carcinoma [123, 124], melanoma ...
20
Case Report Parotid gland and cerebellum metastasis of lung cancer: a case report
... all cancer-related mortalities are caused by lung cancer. Lung squamous cell carcinoma (SCC) is a common type of non-small-cell lung cancer (NSCLC) and the second ...
7